Clinical Trial
[Modern possibilities of chemotherapy in patients with ductal pancreatic adenocarcinoma]
[Article in
Russian]
- PMID: 16826811
Item in Clipboard
Clinical Trial
[Modern possibilities of chemotherapy in patients with ductal pancreatic adenocarcinoma]
[Article in
Russian]
Klin Khir.
2006 Feb.
Abstract
Experience of application of preparation Gemzar as a chemotherapy agent for ductal pancreatic adenocarcinoma was analysed. In 28 patients (main group) chemotherapy using Gemzar preparation was conducted, in 30 patients (control group) chemotherapy was not conducted. The trustworthy differences of life span in patients with unresectable tumors in the main and control groups were noted. Difference of the patients life span after performance of radical pancreatic resection was not trustworthy.
Similar articles
-
[Pancreatic cancer--diagnostics and therapy].Zentralbl Chir. 2003 May;128(5):367. doi: 10.1055/s-2003-40028. Zentralbl Chir. 2003. PMID: 12813632 German. No abstract available.
-
Alleviating Effect of Active Hexose Correlated Compound (AHCC) on Chemotherapy-Related Adverse Events in Patients with Unresectable Pancreatic Ductal Adenocarcinoma.Nutr Cancer. 2016;68(2):234-40. doi: 10.1080/01635581.2016.1134597. Epub 2016 Feb 4. Nutr Cancer. 2016. PMID: 26847832 Clinical Trial.
-
Early recurrence of pancreatic cancer after resection and during adjuvant chemotherapy.Saudi J Gastroenterol. 2012 Mar-Apr;18(2):118-21. doi: 10.4103/1319-3767.93815. Saudi J Gastroenterol. 2012. PMID: 22421717 Free PMC article.
-
[Treatment of pancreatic cancer--surgical point of view].Gan To Kagaku Ryoho. 2007 Jul;34(7):993-6. Gan To Kagaku Ryoho. 2007. PMID: 17637533 Review. Japanese.
-
[Gemzar (gemcitabine)--a new chemotherapeutic agent for pancreatic cancer].Harefuah. 1997 Sep;133(5-6):208-12. Harefuah. 1997. PMID: 9461693 Review. Hebrew. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical